SOX9 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP1409a
Background:
SOX9 recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal.
Other Names:
Transcription factor SOX-9, SOX9
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1409a was selected from the N-term region of human SOX9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: SOX9 {ECO:0000303|PubMed:7990924, ECO:0000312|HGNC:HGNC:11204}
Gene ID: 6662
Primary Accession: P48436
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
SOX9 recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal.
Other Names:
Transcription factor SOX-9, SOX9
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1409a was selected from the N-term region of human SOX9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: SOX9 {ECO:0000303|PubMed:7990924, ECO:0000312|HGNC:HGNC:11204}
Gene ID: 6662
Primary Accession: P48436
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review